Activation takes a brief, pulls context from Intelligence, runs every output through Content Engine, and hands back versions that are channel-ready, claims-cited, and MLR-risk-scored. The orchestrator layer of the OVYN architecture.
Architecture · Layer 03 · Orchestrator
This is Activation, the surface your team uses. Pulls brand context from Intelligence, scores against Content Engine, deploys to your channels.
The pharma team generates strategic guidance, marketing goal, audience research, ISI cluster, learnings from the last campaign. The agency strategist then takes that guidance and refines it into the actual project brief below. This is the jump-off, not the final brief, your agency's strategist (Suzanne, etc.) reads it, edits it, and hands it to the team. The KPI selection here tunes the engine's reporting downstream so awareness campaigns get awareness KPIs, conversion campaigns get conversion KPIs.
Customizable per client template
Output flows directly into the version generator below. KPI choice locks in the report template, if you picked Awareness, performance reports come back as reach/frequency/share-of-voice; Conversion reverses the lens to qualified-lead funnel.
New brief
Generate versions from a project brief
Drop in your campaign brief, audience, and format mix. The engine writes 8–12 versions, each tagged with a claims-library citation and an internal MLR risk score before MLR sees it.
Campaign · indication
Audience
Angle
Brief copy · what was filmed / what we want said
Format mix · pharma DTC library
Est, runtime ~52 sec✓ Pulling claims library, ISI, OPDP guardrails, last 12 months Veeva performance
Activity
Recent generations
GEN-218 · 12 min ago
12 variants · BRF-2026-04-31
by Demo Viewer
38 s
GEN-217 · 1 hr ago
8 variants · BRF-2026-04-30
by Demo Viewer
26 s
GEN-216 · 2 hrs ago
6 variants · BRF-2026-04-29
by OVYN strategy team
22 s
GEN-215 · Yesterday
4 variants · BRF-2026-04-28
by Demo Viewer
18 s
286 variants generated this month across 9 active campaigns. Equivalent traditional agency creative line: ~$84,000.
Active campaigns
Briefs in flight
AllCompound DT-204PipelineDisease state
BRF-2026-04-31Active
Q2 caregiver awareness · 'When you knew it wasn't a heart attack'
Anchored to the essence. Scored on three axes. Labeled into the adapter.
Executions are not random outputs. Every piece runs the same three-stage path: an essence-first prompt grounded in the brand corpus, a three-axis check that gates what moves forward, and a labeling loop where reviewer decisions train the per-brand text adapter over time.
Step 1 · Essence-first prompt
Each execution starts from the brand's essence anchor: thesis, story, truths, anti-positioning, tells. The PromptGraph layer expands the intent into structured generation parameters before any draft is written.
Step 2 · Three-axis check
Every execution is scored on compliance rules (deterministic phrase scan), model self-check (the engine re-reads its own output), and brand-fit identity scoring (0–100, hard floor at 60). All three must pass before a piece moves forward.
Step 3 · Labels feed training
Approved and rejected executions are labeled at /admin/generations. Every approval auto-promotes into the brand's precedent library. The adaptive per-brand model retrieves top-K precedents at inference as match-this-voice anchors. See base vs adaptive at /methodology/adapter-compare.
Three modalities · one brand brain
Text. Image. Reel. Same essence anchor, same audit standard.
Every modality runs the same brand-as-model substrate. The essence anchor, corpus retrieval, forbidden list, and voice rules flow into text generation, image generation, and reel generation through the same brand brain. A change approved in one modality propagates to all three.
Text · essence-anchored prose
Headlines, body copy, email subject lines, social captions, MLR-bound talking points. Three-axis check on every piece. Produced via the brief flow above. Audit drawer surfaces brand-fit score + essence thesis on every output.
Image · brand-locked stills
Hero photography, B&A composites, ad creative, social tiles. Five-axis vision scoring including brand atmosphere match (hard floor at 60). Test via methodology demo; production at brand sandbox.
Reel · short-form video
HCP voiceover, patient atmosphere, B-roll, openers, regulated reels with fair-balance overlay. Seven-axis scoring including pacing + temporal coherence. Compliance overlay rendered deterministically (mandated text never trusted to the model). Production surface lives in admin per brand.
Format gallery · what the engine produces
Email banners · display ads · social
Every brief generates the full pharma format suite, not just social. Email banners (HCP + patient), display banners across IAB sizes, eBlast HTML, IVA frames, detail aids. Each format ships with audience-tuned hook, ISI proximity built in, and an internal MLR risk score.
✉ Email banner · PatientMLR risk · 14
Subject
What if it isn't a heart attack?
Preheader
A guide to rare cardiology indication, and what you can ask your cardiologist.
Compound DT-204 · rilonacept
Rare cardiology indication is rare. It's also frequently mistaken for cardiac events that aren't responding to standard treatment.
Learn the signs →
ISI · Compound DT-204 is contraindicated in patients with active or chronic infections… [Full Important Safety Information auto-injected per audience profile]
✉ Email banner · HCPMLR risk · 11
Subject
RHAPSODY 24-month data · Compound DT-204 in rare cardiology indication
Preheader
Long-term efficacy + durability data, exact stat and footnote pulled from your approved claims library.
Compound DT-204 · rilonacept
The only IL-1 cytokine trap with FDA approval for rare cardiology indication.
Review the data →
ISI · Compound DT-204 is contraindicated in patients with active or chronic infections… [Full Important Safety Information auto-injected per audience profile]
ISI link badge auto-attached · click-out to full prescribing info
How each variant gets made
Essence-first prompt. Three-axis scoring. Labels feed the adapter.
Every variant is generated against the brand's essence anchor (thesis, story, truths, anti-positioning, tells) with corpus retrieval grounding the language. The output is scored on three independent axes: compliance rules, model self-check, and brand-fit identity score. Approved variants auto-promote into the brand's precedent library, and the adaptive per-brand model retrieves top-K precedents on the next generation as match-this-voice anchors. Sharpens with every approval, every precedent citable.
A1 · Essence anchor
Thesis, story, truths, anti-positioning, tells injected as the prompt's identity layer.
A2 · Brand corpus
50–500+ pieces per brand, semantic retrieval at inference time.
A3 · Brand-fit score
Independent from compliance. Can pass compliance and still fail brand-fit.
A4 · Per-brand adapter
Approved variants auto-promote as precedents. Adaptive model retrieves them at inference. Sharpens with every click.
She kept saying it wasn't a heart attack. The third ER visit, someone finally listened.
Rare cardiology indication is rare. It's also frequently mistaken for cardiac events that aren't responding to standard treatment. Compound DT-204 is FDA-approved for adults and children 12 and older who keep having flares.
Learn the signs your team should be asking about.
Citation: [Auto-tagged from approved claims library]
02
✓ VoiceMLR risk · 12
Educational · disease state
Static · 1080×1350
Pericarditis that comes back is a different disease.
Rare cardiology indication is driven by IL-1β. Compound DT-204 is the only FDA-approved IL-1 cytokine trap for the condition, trial-cited efficacy data per the approved claims library.
Talk to your cardiologist about Compound DT-204.
Citation: [Auto-tagged from approved claims library]
03
✓ VoiceMLR risk · 24
Cost & access
Carousel · frame 4 of 8
Compound DT-204 cost shouldn't be the reason you stop the next flare.
Most commercially insured patients pay $10 or less per month with the Compound DT-204 Co-Pay program. Government-insured patients have access via the Patient Assistance Foundation.
See if you qualify for support.
FLAG · Fair-balance: ISI block needs to follow on next frame, currently absent
Citation: [Auto-tagged from approved claims library]
Forward thisOne click to the right page for whoever you need to loop in.
